Night CTPA in a Patient With CKD 4, Metformin, and a Prior Contrast Reaction
A 64-year-old man arrives in the emergency department at 02:00 with sudden-onset dyspnea, pleuritic chest pain, and a heart rate of 114 bpm; SpO2 is 90% on room air. His Wells score is high and his D-dimer is markedly elevated. The emergency physician orders a CT pulmonary angiogram. Chart review shows type 2 diabetes treated with metformin, an eGFR of 26 mL/min/1.73 m2 drawn two days ago, and a reaction to IV contrast six years ago described as hives and flushing that resolved after diphenhydramine, with no wheezing and no drop in blood pressure. A 20-gauge IV is in the right antecubital fossa. The radiologist is at home and reachable by phone. The scanner is fully staffed overnight.
1. The referring clinician asks whether the study should be delayed 13 hours for a steroid premedication regimen. How do you answer, and what does the character of the prior reaction change?
Read the worked answer
Do not delay. The decision hinges on the severity of the index reaction, not on the simple fact that a reaction occurred.
- This was a mild, cutaneous-only reaction (urticaria, flushing, no bronchospasm, no hypotension). Guidelines treat premedication for a prior mild reaction as optional for elective studies; it reduces but does not eliminate breakthrough reactions and is not a prerequisite for contrast.
- A 13-hour oral regimen, or even an accelerated 3-5 hour IV regimen, leaves the patient unmedicated during the window of highest risk in a patient with a high pretest probability of PE. The harm of a delayed or missed PE diagnosis outweighs the small residual risk of a recurrent mild reaction.
- Practical mitigations instead: use a low-osmolar nonionic agent, keep epinephrine, diphenhydramine, oxygen and suction immediately available, and monitor the patient for the first 5-10 minutes after injection.
- If the prior reaction had included laryngospasm, bronchospasm, hypotension, or required epinephrine, the calculus changes: premedicate if time permits, and weigh whether an alternate study answers the question.
- Document the risk-benefit discussion and notify the radiologist by phone.
2. How do the eGFR of 26 and the metformin prescription alter your preparation for this study?
Read the worked answer
Both facts raise real but manageable issues; neither is an absolute contraindication to an urgent study.
Renal function
- eGFR <30 places the patient in the highest risk stratum for contrast-associated acute kidney injury, but risk is not the same as prohibition. When the study is likely to change management (as here), proceed.
- Give isotonic IV crystalloid (e.g., 1 mL/kg/h begun before injection and continued after) unless the patient is in heart failure or fluid-overloaded, in which case discuss with the radiologist.
- Use the lowest contrast volume that produces diagnostic opacification; a lean-body-weight-based protocol and a saline chaser help. Avoid additional contrast phases that add no diagnostic information.
- Recheck renal function at 48-72 hours and note the exposure in the report.
Metformin
- With eGFR <30, hold metformin at the time of the contrast study and recheck renal function at 48 hours; restart if function is stable. Metformin itself does not cause kidney injury - the concern is lactic acidosis if contrast-associated AKI develops and metformin accumulates.
- At eGFR 30-59 no interruption is required, so this patient crosses the threshold that matters.
3. The emergency physician asks for a V/Q scan instead to protect the kidneys. How do you reason through that substitution?
Read the worked answer
Compare the two tests against what this patient needs: a definitive answer, quickly.
- A V/Q scan avoids iodinated contrast entirely and is a legitimate option when the chest radiograph is normal and the patient can cooperate with the breathing maneuvers.
- But V/Q is frequently nondiagnostic in patients with underlying lung disease, and a low-probability V/Q result in a patient with a high Wells score does not exclude PE - the next step is a CTPA anyway, which means the patient receives contrast plus the delay and the extra study.
- CTPA also gives alternative diagnoses (aortic dissection, pneumothorax, pneumonia, pulmonary infarction) that matter in an acutely dyspneic patient, and it is faster in a patient who is tachycardic and hypoxemic.
- Where V/Q genuinely wins: a young patient with normal kidneys but a compelling reason to avoid contrast, a prior severe anaphylactoid reaction, or an inability to lie still.
- Reasonable plan here: proceed with CTPA with renal precautions, and reserve V/Q for the scenario where renal function deteriorates further or IV access fails.